After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for United Therapeutics Corporation (UTHR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $2.24, or 1.01%, to $224.88. The United Therapeutics Corporation has recorded 11,988 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $222.64 and fluctuated between $235.99 as its day high and $221.27 as its day low. The current market capitalization of United Therapeutics Corporation is $10.15B. A total of 1.6 million shares were traded on the day, compared to an average of 449.45K shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, UTHR has seen 52 BUY and 276 SELL insider trades, representing the acquisition of 391,700 and the disposition of 468,626 shares. Over the last 12 months, there were 154 BUYs and 622 SELLs from insiders. Insiders purchased 881,861 shares during that period but sold 958,807.
In the most recent transaction, ROTHBLATT MARTINE A sold 8,000 shares of UTHR for 239.16 per share on Mar 07. After the transaction, the CHAIRPERSON & CEO now owns 121 company shares. In a previous transaction on Mar 06, ROTHBLATT MARTINE A sold 8,000 shares at 247.28 per share. UTHR shares that CHAIRPERSON & CEO owns now total 130.
Among the insiders who sold shares, ROTHBLATT MARTINE A disposed of 8,000 shares on Mar 03 at a per-share price of $247.38. This resulted in the CHAIRPERSON & CEO holding 130 shares of UTHR after the transaction. In another insider transaction, ROTHBLATT MARTINE A sold 8,000 shares at $244.50 per share on Mar 02. Company shares held by the CHAIRPERSON & CEO now total 130.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for UTHR in the last 3 months, the mean price target is $287.58 with high estimates of $375.00 and low estimates of $150.00. In terms of 52-week highs and lows, UTHR has a high of $283.09 and a low of $158.38.
As of this writing, UTHR has an earnings estimate of $4.51 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $5.23 per share and a lower estimate of $3.34. The company reported an EPS of $2.41 in the last quarter, which was -41.60% lower than expectations of $4.13.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 14 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTHR is Hold with a score of 4.42. A total of 11 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 1 thought it should be Sold.
